2015
DOI: 10.1016/j.ijcard.2015.03.130
|View full text |Cite
|
Sign up to set email alerts
|

Whole exome sequencing identifies the TNNI3K gene as a cause of familial conduction system disease and congenital junctional ectopic tachycardia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
41
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(41 citation statements)
references
References 10 publications
0
41
0
Order By: Relevance
“…Similarly, we do not yet know the upper limit of MNDCMs that the mammalian heart can accommodate. Two human families with conduction system disease (tachyarrhythmia) have been identified to carry nonsynonymous coding region point mutations in the TNNI3K gene 44,45 . If TNNI3K is associated with cardiomyocyte cell cycle progression, one possibility is that interference with the process of becoming polyploid, such as perhaps occurs in these two families, might lead to functional defects such as tachyarrhythmia.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, we do not yet know the upper limit of MNDCMs that the mammalian heart can accommodate. Two human families with conduction system disease (tachyarrhythmia) have been identified to carry nonsynonymous coding region point mutations in the TNNI3K gene 44,45 . If TNNI3K is associated with cardiomyocyte cell cycle progression, one possibility is that interference with the process of becoming polyploid, such as perhaps occurs in these two families, might lead to functional defects such as tachyarrhythmia.…”
Section: Discussionmentioning
confidence: 99%
“…8 Multiple gene deletions like the angiotensin-converting enzyme insertion/deletion (ACE I/D) and troponin I-interacting kinase (TNNI3K) have been implicated to predispose to CJET and POJET. [9][10][11] TNNI3K is a cardiac-specific gene, encoding a cardiac troponin I-interacting kinase. Mutations here or in its gatekeeper could lead to altered phosphorylation of its substrates, such as cardiac troponin I, and may result in cardiac dysfunction, cardiac arrhythmia, and dilated cardiomyopathy.…”
Section: Etiopathophysiology and Mechanismmentioning
confidence: 99%
“…This mutation results in the early appearance of stop codon which is anticipated to produce truncated protein lacking partial protein kinase domain along with the C-terminus. For all we know, a premature termination TA B L E 3 Comparison of clinical presentation of cases with TNNI3K mutation Theis, et al (2014) 16 Xi, et al (2015) 17 Fan, et al (2018) 18 Podliesna, et al (2019) 19 Podliesna, et al (2019) 19 Podliesna, codon (PTC) may result in loss of function (LOF) through NMD. 23,24 NMD refers to rapid degradation of mRNAs in transcripts harboring a PTC existing in all eukaryotic cells, which prevents the synthesis of truncated and potentially toxic proteins.…”
Section: Discussionmentioning
confidence: 99%
“…To date, there are only four mutations in TNNI3K that have been found to be relevant with cardiovascular diseases, including three missense mutations and one splicing mutation. [16][17][18][19] Here, we found that a nonsense variant in TNNI3K (NM_015978.2:c.1441C > T), which was not seen in the human gene mutation database (HGMD), may be the cause of cardiac abnormalities.…”
mentioning
confidence: 90%